H. Hausmaninger
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer, Hypoxia, and Metabolism
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Cancer Treatment and Pharmacology
- Lymphatic System and Diseases
Papers in
- Oncology 42
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 5
-
- Breast Cancer Treatment Studies 20
- Co-authors
- R. JakeszMichael GnantE. KubistaHellmut SamoniggW. KwasnySebastian F. SchoppmannGeorg OberhuberBrigitte Mlineritsch
- Journals
- Journal of Clinical Oncology (11 papers)European Journal of Cancer (8 papers)Annals of Hematology (4 papers)Annals of Surgery (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
H. Hausmaninger
52 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 910
- Oncology 1.3k
- Genetics 447
- Pathology and Forensic Medicine 287
- Orthopedics and Sports Medicine 120
Countries citing papers authored by H. Hausmaninger
This map shows the geographic impact of H. Hausmaninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Hausmaninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Hausmaninger more than expected).
Fields of papers citing papers by H. Hausmaninger
This network shows the impact of papers produced by H. Hausmaninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Hausmaninger. The network helps show where H. Hausmaninger may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Hausmaninger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 48 | |
| 2 | 2004 | 16 | |
| 3 | 2004 | 3 | |
| 4 | 2003 | 18 | |
| 5 | Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. | 2002 | 332 |
| 6 | 2002 | 11 | |
| 7 | Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. | 2001 | 159 |
| 8 | 2000 | 191 | |
| 9 | 1999 | 28 | |
| 10 | 1998 | 9 | |
| 11 | 1997 | 18 | |
| 12 | 1996 | 9 | |
| 13 | 1995 | 1 | |
| 14 | 1995 | 9 | |
| 15 | 1991 | 1 | |
| 16 | 1990 | 4 | |
| 17 | 1990 | 17 | |
| 18 | 1989 | 8 | |
| 19 | 1989 | 10 | |
| 20 | 1988 | 23 |
About H. Hausmaninger
H. Hausmaninger is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Reproductive Medicine and Dermatology, having authored 53 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (20 papers), Cancer Treatment and Pharmacology (17 papers), Estrogen and related hormone effects (9 papers), Lymphoma Diagnosis and Treatment (8 papers), HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Cancer Research (910 citations), Oncology (1.3k citations), Genetics (447 citations), Pathology and Forensic Medicine (287 citations) and Orthopedics and Sports Medicine (120 citations). H. Hausmaninger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include R. Jakesz, Michael Gnant, E. Kubista, Hellmut Samonigg, W. Kwasny, Sebastian F. Schoppmann, Georg Oberhuber, Brigitte Mlineritsch, Christian Menzel and Peter Birner. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Hematology, Annals of Surgery and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.